ZyVersa Therapeutics, Inc. (ZVSA)
NASDAQ: ZVSA · Real-Time Price · USD
0.7285
+0.0265 (3.77%)
At close: Jun 12, 2025, 4:00 PM
0.7088
-0.0197 (-2.70%)
Pre-market: Jun 13, 2025, 8:38 AM EDT
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $3.48 million as of June 13, 2025. Its market cap has decreased by -2.08% in one year.
Market Cap
3.48M
Enterprise Value
1.87M
1-Year Change
-2.08%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from $95.47M to $3.48M, a decrease of -96.36%. That is a compound annual growth rate of -62.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2025 | 3.48M | 39.95% |
| Dec 31, 2024 | 2.48M | -47.34% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.26B |
| Johnson & Johnson | 375.28B |
| Novo Nordisk | 353.21B |
| AbbVie | 340.58B |
| UnitedHealth Group | 284.48B |
| Abbott Laboratories | 237.12B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |